Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download
Investment
Features
FeesSafety
Academy
More
Pluang+

Bitcoin may drop to $55,000 before stabilizing, warns 10x Research analysis.

Market News
24 Jun 2026
Crypto Economy
View Source
Bearish
pluang ai news

According to an analysis published on the 10x Research website, Bitcoin could fall to as low as $55,000 before finding a bottom in the current bear market cycle. This suggests that investors should be prepared for further declines before the cryptocurrency stabilizes and potentially recovers. The warning highlights ongoing volatility and uncertainty in the Bitcoin market, signaling caution for retail investors.

More News

Global Therapeutic Apheresis Market to nearly double to $8.94B by 2035 with 7.9% CAGR driven by chronic disease demand.

Global Therapeutic Apheresis Market to nearly double to $8.94B by 2035 with 7.9% CAGR driven by chronic disease demand.

The global therapeutic apheresis market, valued at $3.84 billion in 2025, is projected to grow to $8.94 billion by 2035 at a 7.9% CAGR. Growth is fueled by rising chronic and autoimmune diseases, advances in automated apheresis technology, and expand...

Market News
Bullish
34 minutes ago
Aduro Clean Technologies closes C$9.16M private placement to fund tech development and commercialization.

Aduro Clean Technologies closes C$9.16M private placement to fund tech development and commercialization.

Aduro Clean Technologies completed a private placement raising C$9.16 million by selling 431,884 shares at C$21.20 each. The funds will support technology development, marketing activities, working capital, and general corporate needs. The offering w...

Company Fundamentals
Bullish
59 minutes ago
Aduro Clean Technologies raises C$9.16M in private placement to fund tech development and operations.

Aduro Clean Technologies raises C$9.16M in private placement to fund tech development and operations.

Aduro Clean Technologies completed a private placement raising approximately C$9.16 million by selling 431,884 common shares at C$21.20 each. The funds will support technology development, marketing, working capital, and general corporate purposes. T...

Company Fundamentals
Bullish
59 minutes ago
Mesoblast secures $50M from a new 5-year loan to retire costly short-term debt and fund growth.

Mesoblast secures $50M from a new 5-year loan to retire costly short-term debt and fund growth.

Mesoblast Limited has drawn $50 million from a new five-year loan facility provided by a shareholder, replacing higher-cost short-term debt. This move strengthens Mesoblast's balance sheet by lowering interest costs and removing short-term obligation...

Company Fundamentals
Bullish
2 hours ago
Fanregratinib shows strong Phase II results for advanced intrahepatic cholangiocarcinoma, advancing regulatory review in China.

Fanregratinib shows strong Phase II results for advanced intrahepatic cholangiocarcinoma, advancing regulatory review in China.

HUTCHMED announced positive Phase II trial results for fanregratinib in treating advanced intrahepatic cholangiocarcinoma (ICC) with FGFR2 fusion/rearrangement. The study showed a 42.5% objective response rate and median overall survival of 16.6 mont...

Company Fundamentals
Bullish
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App